Ticker Details
Bio-Rad Laboratories, Inc.Class A Bio-Rad Laboratories Inc manufactures and supplies the life science research, healthcare, analytical chemistry and other markets with a products and systems used to separate complex chemical and biological materials.
IPO Date:	January 2, 1990
Sector:	Healthcare
Industry:	Life Sciences Tools and Services
Market Cap:	$7.54B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$2.62 | 1.14%
Avg Daily Range (30 D):	$4.01 | 1.47%
Avg Daily Range (90 D):	$3.65 | 1.27%

Institutional Daily Volume
Avg Daily Volume:	.11M
Avg Daily Volume (30 D):	.2M
Avg Daily Volume (90 D):	.19M

Trade Size
Avg Trade Size (Sh.):	48
Avg Trade Size (Sh.) (30 D):	19
Avg Trade Size (Sh.) (90 D):	20

Institutional Trades
Total Institutional Trades:	4,356
Avg Institutional Trade:	$9.13M
Avg Institutional Trade (30 D):	$16.47M
Avg Institutional Trade (90 D):	$11.36M
Avg Institutional Trade Volume:	.03M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$11.41M
Avg Closing Trade (30 D):	$19.66M
Avg Closing Trade (90 D):	$13.28M
Avg Closing Volume:	33.34K

News

Apr 3, 2026 @ 7:15 AM Drug Screening Market Trends 2026–2031: Chr... Source: Mordor Intelligence

Mar 20, 2026 @ 11:00 AM ELISpot & FluoroSpot Assay Market Report 2026-2031... Source: Researchandmarkets.Com

Mar 10, 2026 @ 7:32 AM Molecular Diagnostics Market Outlook: Set to Grow ... Source: Mordor Intelligence

Mar 3, 2026 @ 11:30 PM [Latest] Global Microplate Systems Market Size/Sha... Source: Custom Market Insights

Jan 30, 2026 @ 9:59 AM Chromatography Research Report 2026 - Global $13.6... Source: Researchandmarkets.Com

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$27.87		$27.87
Diluted EPS	$27.85		$27.85
Revenue	$2.58B		$2.58B
Gross Profit	$1.34B		$1.34B
Net Income / Loss	$759.9M		$759.9M
Operating Income / Loss	$47.2M		$47.2M
Cost of Revenue	$1.24B		$1.24B
Net Cash Flow	$59.3M		$59.3M
PE Ratio	10.35

Splits
Mar 08, 2002	2:1